You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
香港醫思醫療集團(02138.HK):預計全年銷售額同比升幅不少於10%
格隆匯 04-12 07:58

格隆匯 4 月 12日丨香港醫思醫療集團(02138.HK)發佈公吿,截至2021年3月31日止年度,集團預期錄得:(i)期內銷售額將不少於22億港元,較去年同期升幅不少於10%;(ii)集團所提供的醫療服務銷售額期內下半年較去年同期增長不少於100%及期內較去年同期增長不少於60%;(iii)集團所提供的醫學美容及美容服務期內銷售額較去年同期下跌不多於25%;及(iv)中國內地診所以及服務中心的期內銷售額較去年同期升幅不少於60%。

公吿表示,儘管新型冠狀病毒疾病爆發引致持續的旅遊限制,社交距離及香港所有美容院的另一輪強制關閉而造成了不利的經濟狀況,集團下半年的整體銷售表現仍取得了超過35%的同比增長。在強制關閉的70個工作日內,集團能夠(i)透過主動與客户互動和電子商務活動,以促進本地市場和中國內地的銷售;(ii)促進不同醫療專科之間的交叉銷售;及(iii)完成了對若干醫療機構的收購。董事會認為,隨着香港政府於2021年2月18日放寬預防新型冠狀病毒措施後業務重新開放,強勁的需求將使集團受益。

展望未來,集團對其業務表現持樂觀態度,預期將受益於(i)對新型冠狀病毒測試服務的持續需求;(ii)在可預見的將來提供新型冠狀病毒抗體檢測服務;(iii)可能在跨境旅行使用的健康碼;(iv)遠程醫療服務的普及;及(v)市場的持續整合。集團將密切監察香港政府於2021年2月26日推出的新型冠狀病毒疫苗接種計劃的進展,以及恢復跨境旅行的可能性,並將繼續通過內生增長和收購合併來發展業務,特別聚焦於資訊科技,品牌和服務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account